Pineapple Financial launches the first corporate
Injective (INJ) treasury with a
$100M investment, which sends waves through Wall Street. This positive trend may suggest a good investment opportunity for INJ Coin.
XRP initiates processes with Injective, with Canary filing the
Trump Coin and U.S. made crypto ETFs with the SEC.
Cointelegraph Accelerator and Injective unveil a joint ecosystem acceleration program, which foresees a surge in INJ prices by 2025. Canary's proposal of an Injective ETF triggers the SEC's public input phase. With multi-year resistance waning, INJ seems poised for a significant move. Canary Capital has established a Delaware trust for a staked Injective ETF, bolstering altcoin fund demand. Injective also sees spikes in on-chain usage and wallet numbers, signs of growing credibility. Meanwhile, Bithumb has temporarily suspended INJ transactions due to an Injective network upgrade. Chainlink and Injective attract institutional interest in crypto ETFs, signalling growth. Cointelegraph and Injective launch a blockchain startup accelerator fueled by $1.1M. INJ crypto set to rise as Injective tests EVM compatibility, indicating potential for scalability. The launch of XRPL EVM propels XRP onto Injective as tests show INJ is nearing a crucial resistance level. Deutsche Telekom backs Injective while submitting a filing for a staked Injective ETF. Canary Capital continues to pursue altcoin ETF strategy with its application to launch the first Injective fund with staking rewards.
Injective Coin News Analytics from Thu, 03 Mar 2022 03:34:04 GMT to Wed, 03 Sep 2025 01:41:15 GMT -
Rating 8
- Innovation 7
- Information 9
- Rumor -2
